Opportunity
New York State Contract Reporter #26-173
Secondary Pharmacy Distribution Services for Oral Medications and Suspensions
Posted
July 08, 2026
Respond By
July 29, 2026
Identifier
26-173
NAICS
424210
Roswell Park Comprehensive Cancer Center is seeking proposals for secondary pharmacy distribution services to support its supply of oral medications, oral suspensions, and other pharmaceutical drugs on an as-needed basis. - Government Buyer: - Roswell Park Comprehensive Cancer Center (Roswell Park Cancer Institute Corporation) - Products/Services Requested: - Secondary pharmacy distribution services for oral medications, oral suspensions, and other pharmaceuticals - No specific part numbers or quantities; supply is as-needed - Key Requirements: - Distributor must be DSCSA compliant (Drug Supply Chain Security Act) - Ability to provide both brand-name and generic drugs, including specialty medications - Transparent sourcing with batch-level traceability - Reliable inventory and delivery, including temperature-controlled logistics for sensitive medications - Capability to fulfill urgent orders and provide real-time inventory visibility - Flexible ordering options with low minimums and no long-term commitments - Efficient issue resolution and a dedicated point of contact - Compliance with Roswell Park's insurance minimums and New York State contract clauses - Submission of a full price file of available medications and completion of questionnaires regarding requirements, references, and supplier information - Notable Information: - BluPax Pharmaceuticals, LLC is noted as a previous awardee for a similar contract - Equal employment opportunity compliance is required, including EEO policy statements and staffing plans - The contract term is three years, with two one-year renewal options
Description
Roswell Park Cancer Institute Corp. is seeking proposals from qualified firms to provide secondary pharmaceutical distribution services. The contract involves supplying oral medications, oral suspensions, and other pharmaceutical medications on an as-needed basis. The contract term is three years with two successive one-year renewal terms. Respondents must comply with the requirements set forth in the Request for Proposal and provide answers to the Requirements Questionnaire.